I-Mab (IMAB)
NASDAQ: IMAB · IEX Real-Time Price · USD
1.860
-0.010 (-0.53%)
At close: Mar 28, 2024, 4:00 PM
1.890
+0.030 (1.61%)
After-hours: Mar 28, 2024, 4:53 PM EDT
I-Mab Market Cap
I-Mab has a market cap or net worth of $150.10 million as of March 28, 2024. Its market cap has decreased by -49.83% in one year.
Market Cap
150.10M
Enterprise Value
-155.64M
1-Year Change
-49.83%
Ranking
Category
Stock Price
$1.86
Market Cap Chart
Since January 17, 2020, I-Mab's market cap has decreased from $720.80M to $150.10M, a decrease of -79.18%. That is a compound annual growth rate of -31.21%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 154.50M | 1.64% |
Mar 26, 2024 | 152.00M | -1.11% |
Mar 25, 2024 | 153.70M | -0.52% |
Mar 22, 2024 | 154.50M | 3.34% |
Mar 21, 2024 | 149.50M | -4.78% |
Mar 20, 2024 | 157.00M | 4.39% |
Mar 19, 2024 | 150.40M | 0.60% |
Mar 18, 2024 | 149.50M | -2.73% |
Mar 15, 2024 | 153.70M | 3.36% |
Mar 14, 2024 | 148.70M | -2.17% |
Mar 13, 2024 | 152.00M | 0.53% |
Mar 12, 2024 | 151.20M | 1.14% |
Mar 11, 2024 | 149.50M | -2.22% |
Mar 8, 2024 | 152.90M | 7.60% |
Mar 7, 2024 | 142.10M | -0.56% |
Mar 6, 2024 | 142.90M | 2.36% |
Mar 5, 2024 | 139.60M | -1.20% |
Mar 4, 2024 | 141.30M | -4.46% |
Mar 1, 2024 | 147.90M | 0.54% |
Feb 29, 2024 | 147.10M | -3.79% |
Feb 28, 2024 | 152.90M | - |
Feb 27, 2024 | 152.90M | 6.33% |
Feb 26, 2024 | 143.80M | 6.13% |
Feb 23, 2024 | 135.50M | 4.47% |
Feb 22, 2024 | 129.70M | -1.89% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
High Tide | 153.97M |
DBV Technologies | 153.93M |
Allurion Technologies | 153.33M |
Syros Pharmaceuticals | 152.79M |
CytomX Therapeutics | 147.63M |
Vor Biopharma | 147.24M |
Galectin Therapeutics | 146.58M |
Armata Pharmaceuticals | 146.03M |